What is NDC 63629-5269?

63629-5269 is the product NDC for Anastrozole, Anastrozole 1 mg/1 tablet, listed with the FDA by Bryant Ranch Prepack. It has 10 package NDCs, shown above in 10- and 11-digit form.

Bryant Ranch Prepack, NDC labeler code 63629. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Anastrozole?

38 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Anastrozole NDC 63629-5269 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)63629-5269Labeler and product segments. Claims need a package NDC.

Product NDC at billing width63629-5269Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
63629-5269-0	6362952690063629526900	28 TABLET in 1 BOTTLE, PLASTIC (63629-5269-0)Marketed from Jan 5, 2021
63629-5269-1	6362952690163629526901	30 TABLET in 1 BOTTLE (63629-5269-1)Marketed from Mar 21, 2014
63629-5269-2	6362952690263629526902	20 TABLET in 1 BOTTLE (63629-5269-2)Marketed from Aug 13, 2014
63629-5269-3	6362952690363629526903	90 TABLET in 1 BOTTLE (63629-5269-3)Marketed from Jan 26, 2016
63629-5269-4	6362952690463629526904	4 TABLET in 1 BOTTLE (63629-5269-4)Marketed from Jun 20, 2018
63629-5269-5	6362952690563629526905	6 TABLET in 1 BOTTLE (63629-5269-5)Marketed from Dec 1, 2021
63629-5269-6	6362952690663629526906	10 TABLET in 1 BOTTLE (63629-5269-6)Marketed from Jun 25, 2018
63629-5269-7	6362952690763629526907	40 TABLET in 1 BOTTLE (63629-5269-7)Marketed from Nov 20, 2019
63629-5269-8	6362952690863629526908	12 TABLET in 1 BOTTLE (63629-5269-8)Marketed from Mar 6, 2019
63629-5269-9	6362952690963629526909	14 TABLET in 1 BOTTLE (63629-5269-9)Marketed from Jul 7, 2020

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Anastrozole
Generic name (nonproprietary): anastrozole
Active ingredients: Anastrozole — 1 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Bryant Ranch PrepackNDC labeler code 63629
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 090568
Marketing start: Jun 22, 2010
Listing expires: Dec 31, 2026
Other FDA classes: Aromatase Inhibitors (Mechanism)
Identifiers: Product ID 63629-5269_8a570a78-9fc6-46eb-b8fd-bef140eef78eSPL ID 8a570a78-9fc6-46eb-b8fd-bef140eef78eSPL set ID 19251d0b-279a-49f5-99b2-0e74d7cca479RxCUI 199224UNII 2Z07MYW1AZ
Pharmacologic class: Aromatase Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N463629526900 followed by a unit qualifier and the quantity

Package 63629-5269-00. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Aug 22, 2024.

Indications (excerpt from the label)

Anastrozole is an aromatase inhibitor indicated for: Adjuvant treatment of postmenopausal women with hormone receptor-positive early breast cancer ( 1.1 ) First-line treatment of postmenopausal women with hormone receptor-positive or hormone receptor unknown locally advanced or metastatic breast cancer ( 1.2 ) Treatment of advanced breast cancer in postmenopausal women with disease progression following tamoxifen therapy. Patients with ER-negative disease and patients who did not respond to previous tamoxifen therapy rarely responded to anastrozole ( 1.3 ) 1.1 Adjuvant Treatment Anastrozole tablets are indicated for adjuvant treatment of postmenopausal women with hormone receptor-positive ea…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 63629-5269

What is NDC 63629-5269?: 63629-5269 is the product NDC for Anastrozole, Anastrozole 1 mg/1 tablet, listed with the FDA by Bryant Ranch Prepack. It has 10 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Anastrozole.
What is the active ingredient?: Anastrozole.
Who is the labeler?: Bryant Ranch Prepack, NDC labeler code 63629. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Anastrozole?: 38 other product NDCs are listed under this name. See all Anastrozole NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Anastrozole NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Anastrozole	Anastrozole 1 mg/1	TabletOral	Direct_Rx	72189-682	72189-0682-30
Anastrozole	Anastrozole 1 mg/1	Tablet, Film coatedOral	PD-Rx Pharmaceuticals, Inc.	72789-575	72789-0575-1572789-0575-30
Anastrozoleanastrozole tablets	Anastrozole 1 mg/1	TabletOral	Upsher-Smith Laboratories, LLC	24979-725	24979-0725-0624979-0725-07
Anastrozole	Anastrozole 1 mg/1	TabletOral	AvKARE	42291-016	42291-0016-3042291-0016-90
Anastrozole	Anastrozole 1 mg/1	TabletOral	Direct_Rx	72189-415	72189-0415-30
Anastrozole	Anastrozole 1 mg/1	Tablet, Film coatedOral	Aurobindo Pharma Limited	59651-236	59651-0236-3059651-0236-90
Anastrozole	Anastrozole 1 mg/1	Tablet, Film coatedOral	AvKARE	42291-085	42291-0085-3042291-0085-90
Anastrozole	Anastrozole 1 mg/1	TabletOral	AvPAK	50268-075	50268-0075-15
Anastrozoleanastrozole tablets	Anastrozole 1 mg/1	TabletOral	Avet Pharmaceuticals Inc	23155-857	23155-0857-0323155-0857-0523155-0857-09
Anastrozole	Anastrozole 1 mg/1	TabletOral	Chartwell RX, LLC	62135-490	62135-0490-3062135-0490-90

All 39 Anastrozole NDCs

Other NDCs under ANDA 090568

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 090568
Product	Strength	Form · route	Labeler	Product NDC
Anastrozole	Anastrozole 1 mg/1	TabletOral	Accord Healthcare Inc.	16729-035
Anastrozole	Anastrozole 1 mg/1	TabletOral	A-S Medication Solutions	50090-2453
Anastrozole	Anastrozole 1 mg/1	TabletOral	Proficient Rx LP	63187-080
Anastrozole	Anastrozole 1 mg/1	TabletOral	NuCare Pharmaceuticals,Inc.	68071-1543
Anastrozole	Anastrozole 1 mg/1	TabletOral	NuCare Pharmaceuticals,Inc.	68071-1682
Anastrozole	Anastrozole 1 mg/1	TabletOral	NuCare Pharmaceuticals,Inc.	68071-2791
Anastrozole	Anastrozole 1 mg/1	TabletOral	NuCare Pharmaceuticals,Inc.	68071-5203
Anastrozole	Anastrozole 1 mg/1	TabletOral	Direct_Rx	72189-415
Anastrozole	Anastrozole 1 mg/1	TabletOral	PD-Rx Pharmaceuticals, Inc.	72789-008
Anastrozole	Anastrozole 1 mg/1	TabletOral	Asclemed USA, Inc.	76420-004